Article

Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead

2020-06-20

Abstract excerpt

Structure-based and computer-aided drug design approaches are commonly considered to have been successful in the fields of cancer and antiviral drug discovery but not as much for antibacterial drug development. The search for novel anti-tuberculosis agents is indeed an emblematic example of this trend. Although huge efforts, by consortiums and groups worldwide, dramatically increased the structural coverage of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0fea3f4a-956c-5c90-b47a-96f38b577165
DOI: 10.3390/app10124248

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Structure-Based Drug Design for Tuberculosis: Challenges Still AheadDOI 10.3390/app10124248Read

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosisSemantic proximity Read

In Silico Strategies in Tuberculosis Drug DiscoverySemantic proximity Read

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosisSemantic proximity Read

Bacterial Eukaryotic Type Serine-Threonine Protein Kinases: From Structural Biology to Targeted Anti-Infective Drug DesignSemantic proximity Read

PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.Semantic proximity Read

Structural Biology and the Design of New Therapeutics: From HIV and Cancer to Mycobacterial InfectionsSemantic proximity Read

Comparative Study of Purine and Pyrimidine Nucleoside Analogues Acting on the Thymidylate Kinases of Mycobacterium tuberculosis and of HumansSemantic proximity Read

New and Old Hot Drug Targets in TuberculosisSemantic proximity Read

Tuberculosis drug discovery in the post‐post‐genomic eraSemantic proximity Read

Identification and Validation of Novel Drug Targets in TuberculosisSemantic proximity Read

Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosisSemantic proximity Read

Identification of active molecules against Mycobacterial Shikimate Kinase from Chemical library and their affinity with different domainsSemantic proximity Read